Tag: Harvard Drug Group
Market outlook
January 26, 2010Theresa Flaherty
Harvard Drug Group, respiratory medications, Wayne Vega
Sponsored Stories
HME Medical Distribution brings services closer to Fraser Valley
Philips reaches EUR 288M agreement with US DOJ
AdaptHealth: Business is stabilizing as company works through transition
Motion buys True North Home Health
Shield HealthCare contracts with Astiva Health
CEO of The Compliance Team honored for leadership
Survey: Nasal congestion can impact CPAP adherence
NCPA applauds new PBM disclosure rule
Dexcom invites diabetes community to share their journey with the disease